A meeting of DRAP National Task Force (NTF), was held under the Chairmanship of CEO, DRAP, Dr. Sheikh Akhter Hussain to review the progress so far made during the one month campaign, started on 19.03.2018 on the direction of Apex Supreme Court and to make a future road map for eradication of spurious and unregistered drugs. The participants from provincial governments, AJK and Gilgit Baltistan were apprised that 1217 inspections were conducted and 925 regulatory actions were taken by the NTF. 29 FIRs were approved by the Central Licensing Board against the unregistered / spurious drugs against M/s Everest Pharma and other owners of various companies. The participants highly praised the effectiveness of the campaign and were of the opinion such a coherent and organized campaign has never been conducted before and appreciated the highest level of coordination between the DRAP and Provincial Governments. The participants also lauded the efforts of NTF focal person Mr. Abdul Sattar Soharani. The DRAP focal person for Sindh informed that 125 inspections were conducted including interior Sindh. The main sources of supply of spurious/unregistered were raided which resulted in the positive impact on the market as spurious / unregistered drugs were removed. Focal person of Sindh Government informed that 13 cases were put before the Provincial Quality Control Board, Sindh and permission of 3 FIRs has been given for prosecution. The DRAP focal person from Punjab informed that more than 100 inspections were conducted and 40 regulatory actions were taken against un-registered and smuggled medicines. Huge quantity of raw material was recovered from Cheap Medical Store which was being supplied either to illegal manufacturers or to quacks. The cases of overpricing and sale of drugs without warranty were also registered. It was further informed that 39 cases of unauthorized import of raw material by M/s Everest Pharma are under preparation and soon FIRs will be lodged. A representative of Punjab Government informed that 680 inspections were conducted and 25 FIRs against M/s Everest Pharma will be lodged within ten days. He further informed that more than 90 cases have been registered against M/s Everest Pharma. The focal person of KPK Government informed that 2 cases of spurious / unregistered drugs have been submitted to Provincial Quality Control Board. The focal person of Balochistan Government informed that 37 cases of unregistered drugs were noticed, 50 samples were taken for testing; out of which 15 were of M/s Everest Pharma and 7 have been declared unregistered. He urged DRAP to help in appointment of Chairman Drug Court, Quetta. Representative of Gilgit Baltistan informed that 4 cases of M/s Everest Pharma have been registered. CEO DRAP urged the provincial, AJK and Gilgit Baltistan representatives to recommend names of best performers of NTF for a certificate by DRAP. At the end CEO DRAP stated that complaint cell would continue to function. Focal persons from DRAP and Provincial Governments would be noptified. Chief Secretaries, Inspector Generals and DG Rangers will be written for support of NTF. Wholes sale markets and remote areas will be identified for raids/ inspections in future. Spurious / unregistered drugs declared by the laboratories will be shared on the Whattsapp group. A report of the NTF would be submitted before the Supreme Court after 3 months. ***** ?
PREVIOUS NEXT
